Search Results - "Diagnosis and Pathogenesis of Multiple Sclerosis"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Source: Mult Scler
    Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
    Consejería de Sanidad de la Comunidad de Madrid
    MULTIPLE SCLEROSIS JOURNAL
    r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
    Institut de Recerca Germans Trias i Pujol (IGTP)
    r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
    Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
    Multiple sclerosis, Vol. 29, no. 7, p. 875-883 (2023)
    Multiple sclerosis : clinical and laboratory research
    Multiple Sclerosis Journal

    File Description: application/pdf; pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document; text/xml

  7. 7

    Source: Eur J Neurol
    European Journal of Neurology
    r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
    Institut de Recerca Germans Trias i Pujol (IGTP)
    EUROPEAN JOURNAL OF NEUROLOGY
    r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
    Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
    European journal of neurology, Vol. 30, no. 4, p. 1014-1024 (2023)
    Diouf, I, Malpas, C B, Sharmin, S, Roos, I, Horakova, D, Havrdova, E K, Patti, F, Shaygannejad, V, Ozakbas, S, Izquierdo, G, Eichau, S, Onofrj, M, Lugaresi, A, Alroughani, R, Prat, A, Girard, M, Duquette, P, Terzi, M, Boz, C, Grand'Maison, F, Hamdy, S, Sola, P, Ferraro, D, Grammond, P, Turkoglu, R, Buzzard, K, Skibina, O, Yamout, B, Altintas, A, Gerlach, O, van Pesch, V, Blanco, Y, Maimone, D, Lechner-Scott, J, Bergamaschi, R, Karabudak, R, Iuliano, G, McGuigan, C, Cartechini, E, Barnett, M, Hughes, S, Sa, M J, Solaro, C, Kappos, L, Ramo-Tello, C, Cristiano, E, Hodgkinson, S, Spitaleri, D, Soysal, A, Petersen, T, Slee, M, Butler, E, Granella, F, de Gans, K, McCombe, P, Ampapa, R, Van Wijmeersch, B, van der Walt, A, Butzkueven, H, Prevost, J, Sinnige, L G F, Sanchez-Menoyo, J L, Vucic, S, Laureys, G, Van Hijfte, L, Khurana, D, Macdonell, R, Gouider, R, Castillo-Triviño, T, Gray, O, Aguera-Morales, E, Al-Asmi, A, Shaw, C, Deri, N, Al-Harbi, T, Fragoso, Y, Csepany, T, Perez Sempere, A, Trevino-Frenk, I, Schepel, J, Moore, F & Kalincik, T 2023, 'Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis', European Journal of Neurology, vol. 30, no. 4, pp. 1014-1024. https://doi.org/10.1111/ene.15706

    File Description: application/pdf; pdf

  8. 8

    Source: European Journal of Neuroscience
    European Journal of Neuroscience, 58 (2)

    File Description: application/pdf; application/application/pdf

  9. 9

    Source: Eur J Med Res
    European Journal of Medical Research, Vol 29, Iss 1, Pp 1-13 (2024)

    Subject Terms: 0301 basic medicine, Multiple Sclerosis, Dimethyl Fumarate, Mitoxantrone/therapeutic use [MeSH], Disease-modifying drugs, Blood–brain barrier, Neuroinflammation, Humans [MeSH], Fingolimod Hydrochloride/therapeutic use [MeSH], Multiple Sclerosis/drug therapy [MeSH], Intracerebral haemorrhage, Cerebral Hemorrhage/etiology [MeSH], Multiple Sclerosis/complications [MeSH], Dimethyl Fumarate/therapeutic use [MeSH], Fingolimod Hydrochloride/adverse effects [MeSH], Dimethyl Fumarate/adverse effects [MeSH], Multiple sclerosis, Neurological complications, Pharmacotherapy in MS, CNS immunity, Review, Immunosuppressive Agents/therapeutic use [MeSH], Mitoxantrone/adverse effects [MeSH], Cerebral Hemorrhage/chemically induced [MeSH], Immunosuppressive Agents/adverse effects [MeSH], FOS: Mechanical engineering, Pathology and Forensic Medicine, 03 medical and health sciences, 0302 clinical medicine, Engineering, Progressive multifocal leukoencephalopathy, Biochemistry, Genetics and Molecular Biology, Health Sciences, Humans, Intensive care medicine, Disease, Molecular Biology, Alemtuzumab, Internal medicine, Cerebral Hemorrhage, Polyomavirus-Associated Carcinogenesis and Clinical Manifestations, Psychiatry, Transplantation, Fingolimod Hydrochloride, Natalizumab, Life Sciences, Fingolimod, Mechanical engineering, 3. Good health, Treatment, Diagnosis and Pathogenesis of Multiple Sclerosis, Oncology, Medicine, Stroke (engine), Surgery, Molecular Mechanisms of Amyloidosis, Mitoxantrone, Immunosuppressive Agents

  10. 10
  11. 11

    Source: Sci Rep
    Scientific Reports, Vol 14, Iss 1, Pp 1-26 (2024)

  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20